Save 10% with this forward-looking research bundle pairing next-generation incretin signaling with foundational cellular metabolism.
Price range: $162.00 through $252.00
This bundle combines retatrutide, a cutting-edge triple-agonist peptide under active metabolic research, with NAD⁺, a central coenzyme involved in mitochondrial function and redox biology.
This bundle combines retatrutide, a cutting-edge triple-agonist peptide under active metabolic research, with NAD⁺, a central coenzyme involved in mitochondrial function and redox biology.
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. Synthic Research is a chemical supplier. Synthic Research is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Synthic Research is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
synthic research assistant
